Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


1 2 3 4 5 6
Copyright Notice

Pfizer SWOT

Pfizer—a SWOT Analysis

*****

Pfizer is one of the world's leading research pharmaceutical companies and also one of the ***** most profitable companies. It has a well-respected n*****me known all over the world and commands some of the top *****, advertising, financial, and marketing talent. It produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even ***** American Heart Association recommends the use of drugs such as Lipitor to reduce cholesterol when diet ***** exercise fail ***** reduce this common health problem. High ***** ***** a common ***** problem is only likely to increase with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied ***** Lipitor" which is dangerous for the ***** in ***** future as Lipitor's patent will expire ***** several years, which means it will face competition from cheaper, generic ***** (*****, 2007). Pfizer's reputation has ***** been tainted by ***** association ***** Celebrex, a pain medication that has been tied to increased risk of heart *****s, in comparison to over-the-counter painkillers. The prominence of the Pfizer advertising campaign for this drug, followed by its rapid f***** from grace undoubtedly damaged the company's trusted name.

***** also manufactures Zoloft, an antidepressant that was widely criticized for ***** over-prescription to teenager, and possibly causing increased suicidal thoughts in ***** population. The company website now states that the drug is not advised for people under the age of 17. Antidepressants ***** 'lifestyle' *****s like Viagra have come under increased media scrutiny and used as examples of the over-prescription of medication in ***** American healthcare system in general. Healthcare in America is grow*****g more and ***** expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay ***** drugs.

Now, Exubera, "the first ***** so far only commercially available inhaled-insulin diabetes treatment," ***** on ***** verge ***** turning in***** an "expensive failure" as Pfizer "***** been dogged by questi*****s about its safety, cost and convenience" (Berenson, *****).

Opportunities

According to the ***** press release section of its website, discomfort associated with fibromyaglia, a ***** chronic pain condition, has ***** shown ***** be significantly reduced by a new drug developed by Pfizer c*****lled Lyrica, "according to study results presented ***** at the American Academy ***** Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has ***** developed a new AIDS ***** called Maraviroc, which is likely to considerably improve and extend the life of AIDS patients who take the drug, ***** ***** researchers at the University of Pittsburg and Columbia University (Altman & Pollock, 2007).

Threats

Both Merck and Schering-Plough, two of Pfizer's greatest rivals, plan to combine forces ***** develop a medicine to rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit the market when ***** patent expires in a few *****" ("Merck and Schering-Plough Plan A*****her Cholesterol Drug,"

. . . . [END OF THESIS PAPER PREVIEW]

Download full paper (and others like it)    |    Order a brand new, customized paper

© 2001–2018   |   Term Paper about Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Book Report Sample